Kantaro Sees Important Role For New Antibody Test During Next Phase Of Pandemic

 
• By Reed Miller

The company is planning to produce up to 10 million COVID-SeroKlir SARS-CoV-2 IgG antibody test kits a month through a partnership with Bio-Techne.

The coronavirus spike protein that mediates coronavirus entry into host cell
• Source: shutterstock.com (Design Cells/Getty Images/iStockphoto)

More from Clinical Trials

More from R&D